A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2004
12/15/2004	EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
12/15/2004	EP1121448B1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II
12/15/2004	EP1119543B1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor
12/15/2004	EP1068180B1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors
12/15/2004	EP1025211B1 Hyaluronan synthase gene and uses thereof
12/15/2004	EP0988391B1 Recombinant adenoviral vectors comprising a splicing sequence
12/15/2004	EP0968290B1 Anti-alphavbeta3 humanized monoclonal antibodies
12/15/2004	EP0938304B1 Isovaleramide for the treatment of convulsions, epilepsy, headache and spasticity
12/15/2004	EP0869816B1 Dry compositions comprising hydrophobic stabilizers
12/15/2004	CN1555379A Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
12/15/2004	CN1555377A 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity
12/15/2004	CN1555375A Compounds for inhibiting the release of inflammatory cytokines
12/15/2004	CN1555374A Novel pyridine-substituted pyrazolopyridine derivatives
12/15/2004	CN1555372A Pyrane derivatives as both ace- and nep- inhibitors
12/15/2004	CN1555367A 3-substituted-4-pyrimidone derivatives
12/15/2004	CN1555359A Alkyl urea vitamin A protagonist i
12/15/2004	CN1555358A CCR-3 receptor antagonists v
12/15/2004	CN1555357A Substituied ureaalkyl urea vitamin A protagonist ii
12/15/2004	CN1555356A Bisphenol derivative as NHE-3 inhibitor
12/15/2004	CN1555355A Substituted 4-aminocyclohexanol derivatives
12/15/2004	CN1555351A Method for the preparation of unsaturated hydroxy fatty acids and their esters, their use in pharmaceutical and/or cosmetic preparations
12/15/2004	CN1555271A Interleukin-12 as a veterinary vaccine adjuvant
12/15/2004	CN1555268A Therapeutic agents comprising pro-apoptotic proteins
12/15/2004	CN1555267A Method of treating middle ear infections
12/15/2004	CN1555266A Hormone replacement therapy
12/15/2004	CN1555257A Ascites preventives for poultry
12/15/2004	CN1555252A Topical composition for follicular delivery of an ornithine decarboxylase inhibitor
12/15/2004	CN1554649A Metabotropic glutamate receptor antagonists for treating central nervous system diseases
12/15/2004	CN1554444A Endothelial cell proliferation inhibitor and method of use
12/15/2004	CN1554442A Non target point tissue protective agent in radiation therapy
12/15/2004	CN1554425A Oral medicine for treating dementia and feeblemindedpess
12/15/2004	CN1554409A Medicine for tonifying kidney, promoting generation of vital essence and reinforcing primordial qi, and strengthening and its preparing method
12/15/2004	CN1554400A Use of seniawinii in preparing anti-depression, improving brain or/and defatting medicine or food
12/15/2004	CN1554399A Use of Hubei erectum in preparing anti-depression, anti-anxiety or/and improving, brain medicine or food
12/15/2004	CN1554343A Compounds for treating fibromyalgia and chronic fatigue syndrome
12/15/2004	CN1554341A Compounds for treating fibromyalgia and chronic fatigue syndrome
12/15/2004	CN1179972C Growth hormone secretagogues
12/15/2004	CN1179970C Purine derivatives
12/15/2004	CN1179961C Sulfonamides for treatment of endothelin-mediated disorders
12/15/2004	CN1179960C Indole derivatives and their use for treamtent of osteoporosis amongst other applications
12/15/2004	CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them
12/15/2004	CN1179952C Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors
12/15/2004	CN1179752C Benzodiazapine compounds containing imidazole propanamido and its preparing process and application
12/15/2004	CN1179748C Stabilized pharmaceutical composition in lyophilized form
12/14/2004	US6831286 Method for determining a tilt angle of an optical pickup head
12/14/2004	US6831199 Pyrimidine compounds and derivatives thereof
12/14/2004	US6831196 Such as benzylsulfonyl-D-Ser-Gly-4-amidinobenzylamide, HCl salt; for treatment of malign tumors/metastatic spread
12/14/2004	US6831178 Crystal structure; stability; bioavailability
12/14/2004	US6831105 For therapy and prophylaxis of cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/14/2004	US6831096 Effective against both A and B forms of influenza; oral bioavailability
12/14/2004	US6831094 For therapy of central nervous system disorders such as anxiety, depression, motor disorders
12/14/2004	US6831089 1,4-di-substituted piperidines, some of which have M2 selectivity even higher than that of 3-alpha-chloroimperialine for treating cognitive disorders such as Alzheimer's disease
12/14/2004	US6831085 Methods and compositions utilizing quinazolinones
12/14/2004	US6831083 Pyrazoline derivative or tetrahydropyridazine derivative and medicinal use thereof
12/14/2004	US6831080 Cinnamide derivatives as KCNQ potassium channel modulators
12/14/2004	US6831078 3-aryl substituted having halo or alkylhalo groups; anxiety, epilepsy; presurgery muscle relaxant
12/14/2004	US6831075 Heterocyclic substituted pyrazolones
12/14/2004	US6831073 Treating postmenopausal estrogenic deficiencies without appearance of osteoporosis and/or withdrawal bleeding; continuously administering free or esterified estradiol and nomegestrol acetate
12/14/2004	US6831066 Amyloid precursor proteins with improved bioavailability; for treament of Alzheimer's disease
12/14/2004	US6831065 Anti-inflammatory compounds and uses thereof
12/14/2004	US6831059 Compositions and methods for treating gonadotrophin related illnesses
12/14/2004	US6830894 Compounds and methods for modulating claudin-mediated functions
12/14/2004	US6830760 Glyburide composition
12/14/2004	US6830750 Reduction of oxidative stress factors with Lactobacillus plantarum
12/14/2004	US6830749 Antitumor agents; gene therapy
12/14/2004	US6830744 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
12/14/2004	CA2180867C Monomeric diols and phosphate linked oligomers formed therefrom
12/13/2004	CA2470263A1 New benzothiazine and benzothidiazine derivatives, their process of production and pharmaceutical compositions contained therein
12/13/2004	CA2470065A1 New derivatives of benzothiazine and benzothidiazine, preparation process thereof, and the pharmaceutical compounds containing them
12/09/2004	WO2004106511A1 OLIGO DOUBLE-STRANDED RNA INHIBITING THE EXPRESSION OF Bcl-2 AND MEDICINAL COMPOSITION CONTAINING THE SAME
12/09/2004	WO2004106348A1 Aminomethyl-substituted fluorothiazolobenzimidazole derivative
12/09/2004	WO2004106323A1 Method for producing cyclic diamine derivative or salt thereof
12/09/2004	WO2004106317A1 Benzofuran compound and medicinal composition containing the same
12/09/2004	WO2004106312A1 Novel 2-aminoselenazoline derivative and use thereof
12/09/2004	WO2004106290A1 Amino alcohol derivatives, phamaceutical compositions containing the same, and use of both
12/09/2004	WO2004106283A1 Amino alcohol derivative, medicinal composition containing the same, and uses of these
12/09/2004	WO2004106280A1 CaSR ANTAGONIST
12/09/2004	WO2004105764A1 (3- ((quinazolin-4-yl) amino )-1h-pyrazol-1-yl) acetamide derivatives and related compounds as aurora kinase inhibitors for the treatment of proliferative diseases such as cancer
12/09/2004	WO2004105758A1 Use of tripolidine in providing refreshedness on waking
12/09/2004	WO2004105739A1 Compositions and foods and drinks contiaing higher fatty acid derivative
12/09/2004	WO2004105737A2 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
12/09/2004	WO2003097051A3 Use of compounds that are effective as selective opiate receptor modulators
12/09/2004	WO2003090687A8 Using heat shock proteins to increase immune response
12/09/2004	WO2003082898A3 Novel analogues of glucose-dependent insulinotropic polypeptide
12/09/2004	WO2003080582A3 Fredericamycin derivatives
12/09/2004	WO2003072114A9 Vascular therapeutics
12/09/2004	WO2003057835A3 Pak5-related compositions and methods
12/09/2004	WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence
12/09/2004	US20040249175 Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol
12/09/2004	US20040249167 Substituted benzopyrans as selective estrogen receptor-beta agonists
12/09/2004	US20040249161 Biphenyl-derivatives as p38-kinase inhibitors
12/09/2004	US20040249159 Novel piperidin-2,6-dione disulphate salts and their use for the treatment of stress related affective disorders
12/09/2004	US20040249153 For therapy of inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors
12/09/2004	US20040249135 Using high energy electromagnetic waves to destroy viral, prion, bacterial, fungal and parasitic contaminants in immunoglobulin; antibody purity and immunotherapy
12/09/2004	US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004	US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004	US20040248992 Method and composition for inhibiting arteriosclerosis
12/09/2004	US20040248991 comprises ubiquinones; decreasing amount of urinary 8-hydroxydeoxyquanosine in diabetic animals
12/09/2004	US20040248986 Treating aggressive breast cancer with tesmilifene hydrochloride; synergistic effect combine with other chemotherapeutic agent like doxorubicin, taxanes
12/09/2004	US20040248978 Synergistic pain treatment, side effect reduction; a mixture of pregabalin or tiagabine and 2-[4-(2-fluorobenzyloxy) benzylamino] propanamide

1 ... 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 ... 1564